Hepatic estrogen receptor in human liver disease

Area of Science:

• Endocrinology
• Hepatology
• Molecular Biology

Background:

• Human liver possesses estrogen receptors, making it sensitive to estrogenic effects.
• Estrogen's role in liver metabolism and disease is recognized, yet data on receptor levels in diseased liver is limited.

Purpose of the Study:

• To investigate estrogen receptor (ER) levels in human liver tissue affected by diseases linked to oral contraceptive use.
• To compare ER levels in normal liver tissue versus neoplastic liver tissue (hepatic adenoma, focal nodular hyperplasia).

Main Methods:

• Performed binding studies on cytosol and nuclei from human liver tissue samples.
• Quantified high-affinity, low-capacity, saturable, and specific binding for estrogens.

Main Results:

• Cytosolic and nuclear estrogen receptors were detected in human hepatic adenoma and focal nodular hyperplasia.
• Nuclear ER levels were significantly higher in neoplastic liver tissue compared to normal liver tissue.
• A hepatic adenoma from a patient on tamoxifen showed no cytosolic ER and reduced nuclear ER levels.

Conclusions:

• Neoplastic liver tissue exhibits higher nuclear estrogen receptor levels than normal tissue.
• These findings indicate a potential for enhanced hormone responsiveness in neoplastic liver.
• Tamoxifen treatment may influence estrogen receptor expression in hepatic adenomas.